Literature DB >> 20855856

Low disease risk in relatives of north african lrrk2 Parkinson disease patients.

A R Troiano1, A Elbaz, E Lohmann, S Belarbi, M Vidailhet, A-M Bonnet, S Lesage, P Pollak, C Cazeneuve, M Borg, J Feingold, A Dürr, M Tazir, A Brice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20855856     DOI： 10.1212/WNL.0b013e3181f39a2e

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Authors:  R Saunders-Pullman; K Stanley; M San Luciano; M J Barrett; V Shanker; D Raymond; L J Ozelius; S B Bressman
Journal:  Neurosci Lett       Date:  2011-04-12       Impact factor: 3.046

Review 2.  LRRK2 Pathways Leading to Neurodegeneration.

Authors:  Mark R Cookson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 3.  Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2011-03-23       Impact factor: 11.685

4.  Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.

Authors:  Claustre Pont-Sunyer; Susan Bressman; Deborah Raymond; Amanda Glickman; Eduardo Tolosa; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2015-05-07       Impact factor: 10.338

5.  Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.

Authors:  Marta San Luciano; Caroline M Tanner; Cheryl Meng; Connie Marras; Samuel M Goldman; Anthony E Lang; Eduardo Tolosa; Birgitt Schüle; J William Langston; Alexis Brice; Jean-Christophe Corvol; Stefano Goldwurm; Christine Klein; Simone Brockman; Daniela Berg; Kathrin Brockmann; Joachim J Ferreira; Meriem Tazir; George D Mellick; Carolyn M Sue; Kazuko Hasegawa; Eng King Tan; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2020-07-14       Impact factor: 10.338

6.  Novel recruitment strategy to enrich for LRRK2 mutation carriers.

Authors:  Tatiana Foroud; Danielle Smith; Jacqueline Jackson; Jennifer Verbrugge; Cheryl Halter; Leah Wetherill; Katherine Sims; Winnie Xin; Vanessa Arnedo; Shirley Lasch; Kenneth Marek
Journal:  Mol Genet Genomic Med       Date:  2015-05-06       Impact factor: 2.183

Review 7.  Preventing Parkinson's Disease: An Environmental Agenda.

Authors:  Briana R De Miranda; Samuel M Goldman; Gary W Miller; J Timothy Greenamyre; E Ray Dorsey
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 8.  Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease.

Authors:  Laura J Smith; Chiao-Yin Lee; Elisa Menozzi; Anthony H V Schapira
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.